CASTLE BIOSCIENCES INC - Common Stock (CSTL)

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
29,328,179
Total 13F shares
26,505,010
Share change
+397,255
Total reported value
$706,396,254
Put/Call ratio
28%
Price per share
$26.65
Number of holders
197
Value change
+$8,987,296
Number of buys
100
Number of sells
92

Institutional Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q4 2024

As of 31 Dec 2024, CASTLE BIOSCIENCES INC - Common Stock (CSTL) was held by 197 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,505,010 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, WASATCH ADVISORS LP, PRINCIPAL FINANCIAL GROUP INC, DIMENSIONAL FUND ADVISORS LP, CITADEL ADVISORS LLC, UBS Group AG, Portolan Capital Management, LLC, Bellevue Group AG, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 197 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.